The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets

被引:6
|
作者
Zakaria, Zaida [1 ]
Othman, Zaidatul Akmal [1 ,2 ]
Nna, Victor Udo [3 ]
Mohamed, Mahaneem [1 ,4 ]
机构
[1] Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
[2] Univ Sultan Zainal Abidin, Fac Med, Unit Physiol, Kuala Terengganu, Malaysia
[3] Univ Calabar, Coll Med Sci, Fac Basic Med Sci, Dept Physiol, Calabar, Nigeria
[4] Univ Sains Malaysia, Sch Med Sci, Unit Integrat Med, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
关键词
Medicinal plants; natural products; supplementation; hepatic lipid metabolism; non-alcoholic fatty liver disease; ELEMENT-BINDING PROTEIN-1C; ACTIVATED RECEPTOR-ALPHA; ADIPOSE TRIGLYCERIDE LIPASE; MESSENGER-RNA EXPRESSION; HORMONE-SENSITIVE LIPASE; ACETYL-COA CARBOXYLASE; DE-NOVO LIPOGENESIS; HIGH-FRUCTOSE DIET; INDUCED OBESE MICE; NF-KAPPA-B;
D O I
10.1080/13813455.2021.1939387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imbalance in hepatic lipid metabolism can lead to an abnormal triglycerides deposition in the hepatocytes which can cause non-alcoholic fatty liver disease (NAFLD). Four main mechanisms responsible for regulating hepatic lipid metabolism are fatty acid uptake, de novo lipogenesis, lipolysis and fatty acid oxidation. Controlling the expression of transcription factors at molecular level plays a crucial role in NAFLD management. This paper reviews various medicinal plants and their bioactive compounds emphasising mechanisms involved in hepatic lipid metabolism, other important NAFLD pathological features, and their promising roles in managing NAFLD through regulating key transcription factors. Although there are many medicinal plants popularly investigated for NAFLD treatment, there is still little information and scientific evidence available and there has been no research on clinical trials scrutinised on this matter. This review also aims to provide molecular information of medicinal plants in NALFD treatment that might have potentials for future scientifically controlled studies.
引用
收藏
页码:1262 / 1278
页数:17
相关论文
共 50 条
  • [1] Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
    Bagherniya, Mohammad
    Nobili, Valerio
    Blesso, Christopher N.
    Sahebkar, Amirhossein
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 213 - 240
  • [2] Hepatic lipid metabolism and non-alcoholic fatty liver disease
    Tessari, P.
    Coracina, A.
    Cosma, A.
    Tiengo, A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (04) : 291 - 302
  • [3] Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
    Gong, Zhenwei
    Tas, Emir
    Yakar, Shoshana
    Muzumdar, Radhika
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 455 (0C) : 115 - 130
  • [4] Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
    David Højland Ipsen
    Jens Lykkesfeldt
    Pernille Tveden-Nyborg
    Cellular and Molecular Life Sciences, 2018, 75 : 3313 - 3327
  • [5] Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
    Ipsen, David Hojland
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (18) : 3313 - 3327
  • [6] The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: Molecular mechanism and promising therapeutic targets
    Yu, Shenglan
    Wang, Zhengtao
    Ding, Lili
    Yang, Li
    LIFE SCIENCES, 2020, 246
  • [7] Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
    Musso, Giovanni
    Gambino, Roberto
    Cassader, Maurizio
    PROGRESS IN LIPID RESEARCH, 2009, 48 (01) : 1 - 26
  • [8] Retinoids as Promising Treatment for Non-alcoholic Fatty Liver Disease
    Tsuchiya, Hiroyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (08): : 903 - 909
  • [9] Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver
    Ramos, Leticia F.
    Silva, Caio M.
    Pansa, Camila C.
    Moraes, Karen C. M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (01) : 25 - 40
  • [10] Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease
    Rui Guo
    Emily C Liong
    Kwok Fai So
    Man-Lung Fung
    George L Tipoe
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (02) : 139 - 144